Moody Aldrich Partners LLC Alkermes Plc. Transaction History
Moody Aldrich Partners LLC
- $475 Million
- Q4 2024
A detailed history of Moody Aldrich Partners LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 82,473 shares of ALKS stock, worth $2.23 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
82,473
Previous 84,907
2.87%
Holding current value
$2.23 Million
Previous $2.38 Million
0.21%
% of portfolio
0.5%
Previous 0.47%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
383Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$786 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$499 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$331 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$238 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$204 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.43B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...